JP2007529218A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529218A5
JP2007529218A5 JP2007503564A JP2007503564A JP2007529218A5 JP 2007529218 A5 JP2007529218 A5 JP 2007529218A5 JP 2007503564 A JP2007503564 A JP 2007503564A JP 2007503564 A JP2007503564 A JP 2007503564A JP 2007529218 A5 JP2007529218 A5 JP 2007529218A5
Authority
JP
Japan
Prior art keywords
gene
polymorphism
codon
substitution
promoter region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007503564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529218A (ja
JP5129563B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/005601 external-priority patent/WO2005090602A2/en
Publication of JP2007529218A publication Critical patent/JP2007529218A/ja
Publication of JP2007529218A5 publication Critical patent/JP2007529218A5/ja
Application granted granted Critical
Publication of JP5129563B2 publication Critical patent/JP5129563B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007503564A 2004-03-18 2005-03-18 視神経症に対する感受性を診断または予測するための方法 Expired - Fee Related JP5129563B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US55398604P 2004-03-18 2004-03-18
US60/553,986 2004-03-18
US60470404P 2004-08-27 2004-08-27
US60/604,704 2004-08-27
US60735904P 2004-09-07 2004-09-07
US60/607,359 2004-09-07
PCT/JP2005/005601 WO2005090602A2 (en) 2004-03-18 2005-03-18 Method for diagnosing or predicting susceptibility to optic nueropathy

Publications (3)

Publication Number Publication Date
JP2007529218A JP2007529218A (ja) 2007-10-25
JP2007529218A5 true JP2007529218A5 (https=) 2008-05-08
JP5129563B2 JP5129563B2 (ja) 2013-01-30

Family

ID=34979405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007503564A Expired - Fee Related JP5129563B2 (ja) 2004-03-18 2005-03-18 視神経症に対する感受性を診断または予測するための方法

Country Status (3)

Country Link
US (1) US8182990B2 (https=)
JP (1) JP5129563B2 (https=)
WO (1) WO2005090602A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2619303T3 (es) 2005-06-01 2017-06-26 Edison Pharmaceuticals, Inc. Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
JP5308328B2 (ja) 2006-04-04 2013-10-09 シングレックス，インコーポレイテッド トロポニンの分析のための高感度のシステムおよび方法
KR20100016525A (ko) * 2007-04-17 2010-02-12 산뗀세이야구가부시기가이샤 녹내장 진행 리스크의 판정 방법
MX363223B (es) 2008-09-10 2019-03-15 Bioelectron Tech Corp Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
WO2010044459A1 (ja) * 2008-10-16 2010-04-22 独立行政法人国立病院機構 緑内障のリスクの予測方法
JP4515524B2 (ja) * 2008-11-27 2010-08-04 株式会社メニコン 正常眼圧緑内障疾患感受性遺伝子及びその利用
US20100197537A1 (en) * 2009-02-02 2010-08-05 R.T. Vanderbilt Company, Inc. Ashless lubricant composition
US9315760B2 (en) 2009-02-02 2016-04-19 Vanderbilt Chemicals, Llc Ashless lubricant composition
EA201101576A1 (ru) * 2009-04-28 2012-04-30 Эдисон Фармасьютикалз, Инк. Лекарственная форма токотриенол хинонов для лечения офтальмических (глазных) заболеваний
CA2777479C (en) 2009-04-28 2017-10-17 Ptc Therapeutics, Inc. Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
WO2010144358A1 (en) 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels
GB201006197D0 (en) * 2010-04-14 2010-06-02 Univ Edinburgh Genetic markers for PDB
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
RU2597784C2 (ru) * 2014-11-19 2016-09-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития первичной открытоугольной глаукомы у индивидуумов в зависимости от наличия/отсутствия сопутствующей патологии глаз
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
JP7072803B2 (ja) * 2016-06-30 2022-05-23 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
IT201700079495A1 (it) * 2017-07-14 2019-01-14 Optikon 2000 Spa Sistema e metodo di controllo della pressione di infusione oculare per interventi di chirurgia oftalmica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT943014E (pt) * 1996-12-05 2007-03-30 Alcon Mfg Ltd Métodos para diagnóstico do glaucoma e descoberta de farmacos antiglaucoma
US6475724B1 (en) * 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
AU2001294559A1 (en) * 2000-09-11 2002-03-26 Dzgenes, L.L.C. Endothelin-1 promoter polymorphism
WO2002024747A2 (en) * 2000-09-19 2002-03-28 Epidauros Biotechnologie Ag Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications

Similar Documents

Publication Publication Date Title
JP2007529218A5 (https=)
CN103667326B (zh) 高血压易感基因组的鉴定
BR112016022582B1 (pt) Marcadores mitocondriais de doenças neurodegenerativas
WO2006096737A2 (en) Diagnostic and therapeutic target for macular degeneration
US7435541B2 (en) Restriction enzyme genotyping
CN103874526A (zh) 预测补体介导的疾病的发展的方法
JP2013074888A (ja) ＩＬ２８Ｂ（ｒｓ８０９９９１７）とＩＴＰＡ（ｒｓ１１２７３５４）の変異を検出する方法
WO2011148715A1 (ja) 正常眼圧緑内障疾患感受性遺伝子及びその利用
JP5226256B2 (ja) 加齢黄斑変性症の発症リスクの予測方法
CN106987635B (zh) Ntn1基因易感snp位点及其应用
JP5721150B2 (ja) 加齢黄斑変性症の発症リスクの予測方法
JP6053681B2 (ja) イヌの緑内障を診断する方法及びキット
US20110104154A1 (en) Single nucleotide polymorphisms and genes associated with age-related macular degeneration
US20030082537A1 (en) Methods for genetic analysis of DNA to detect sequence variances
JP5169306B2 (ja) プロスタサイクリン受容体遺伝子のｓｎｐを利用した緑内障の発症リスクの判定方法
JP6342627B2 (ja) 筋萎縮性側索硬化症の新規病因遺伝子
WO2016180725A1 (en) Diagnosis of dementia with lewy bodies
RU2701375C1 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ ГЕНОТИПА ЧЕЛОВЕКА ПО МУТАЦИИ c.496AG B 6 ЭКЗОНЕ ГЕНА DPYD
RU2709645C1 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ ГЕНОТИПА ЧЕЛОВЕКА ПО МУТАЦИИ с.1236GA В 11 ЭКЗОНЕ ГЕНА DPYD
RU2709710C1 (ru) Способ определения генотипа человека по мутации ivs14+1ga b 14 интроне гена dpyd
JP5002746B2 (ja) 抗うつ薬に対する反応性予測に有用な遺伝子多型
JP5594655B2 (ja) 網膜色素線条症の原因変異を判定するための方法及びこれに使用されるオリゴヌクレオチド
WO2006068111A1 (ja) ＰＰＡＲγ遺伝子の遺伝子多型に関連する表現型の判定方法
CN1847257A (zh) 一种与肥厚型心肌病中心肌肥厚程度相关的单核苷酸多态性及其用途
JP2011024457A (ja) インスリン抵抗性のリスク評価方法、空腹時血中インスリン濃度のリスク評価方法、及びインスリン抵抗性リスク評価用遺伝子多型タイピングキット